Annual Net Margin
39.72%
+56.72%+333.65%
31 December 2023
Summary:
Ligand Pharmaceuticals Incorporated annual net profit margin is currently 39.72%, with the most recent change of +56.72% (+333.65%) on 31 December 2023. During the last 3 years, it has risen by +41.55% (+2270.49%). LGND annual net margin is now -30.32% below its all-time high of 57.00%, reached on 31 December 2018.LGND Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Margin
-13.84%
+111.15%+88.93%
30 September 2024
Summary:
Ligand Pharmaceuticals Incorporated quarterly net profit margin is currently -13.84%, with the most recent change of +111.15% (+88.93%) on 30 September 2024. Over the past year, it has increased by +17.42% (+55.73%). LGND quarterly net margin is now -114.51% below its all-time high of 95.38%, reached on 31 March 2023.LGND Quarterly Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LGND Net Margin Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +333.6% | +55.7% |
| 3 y3 years | +2270.5% | -165.4% |
| 5 y5 years | -30.3% | +77.5% |
LGND Net Margin High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +333.6% | -114.5% | +88.9% |
| 5 y | 5 years | -30.3% | +333.6% | -114.5% | +88.9% |
| alltime | all time | -30.3% | +105.0% | -114.5% | +99.1% |
Ligand Pharmaceuticals Incorporated Net Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -13.84%(-88.9%) |
| June 2024 | - | -124.99%(-293.1%) |
| Dec 2023 | 39.72%(-333.6%) | 64.72%(-307.0%) |
| Sept 2023 | - | -31.26%(-459.7%) |
| June 2023 | - | 8.69%(-90.9%) |
| Mar 2023 | - | 95.38%(-374.9%) |
| Dec 2022 | -17.00%(-171.9%) | -34.70%(-5202.9%) |
| Sept 2022 | - | 0.68%(-138.0%) |
| June 2022 | - | -1.79%(-95.8%) |
| Mar 2022 | - | -42.13%(+187.0%) |
| Dec 2021 | 23.66%(-1392.9%) | -14.68%(-169.3%) |
| Sept 2021 | - | 21.17%(-41.7%) |
| June 2021 | - | 36.29%(+10.5%) |
| Mar 2021 | - | 32.83%(+168.7%) |
| Dec 2020 | -1.83%(-103.2%) | 12.22%(-176.3%) |
| Sept 2020 | - | -16.01%(-130.0%) |
| June 2020 | - | 53.32%(-173.3%) |
| Mar 2020 | - | -72.77%(+166.9%) |
| Dec 2019 | - | -27.27%(-55.6%) |
| Sept 2019 | - | -61.48%(+6.5%) |
| June 2019 | - | -57.71%(-19.0%) |
| Dec 2018 | 57.00%(+540.4%) | -71.29%(-187.7%) |
| June 2018 | - | 81.25%(+0.8%) |
| Mar 2018 | - | 80.63%(-680.5%) |
| Dec 2017 | 8.90%(-693.3%) | -13.89%(-155.0%) |
| Sept 2017 | - | 25.25%(+16.7%) |
| June 2017 | - | 21.64%(+24.7%) |
| Mar 2017 | - | 17.35%(-311.8%) |
| Dec 2016 | -1.50%(-108.1%) | -8.19%(-268.5%) |
| Sept 2016 | - | 4.86%(-115.4%) |
| June 2016 | - | -31.61%(-241.8%) |
| Mar 2016 | - | 22.29%(-25.5%) |
| Dec 2015 | - | 29.92%(+479.8%) |
| Mar 2015 | - | 5.16%(-83.2%) |
| Dec 2014 | 18.63%(-20.1%) | 30.68%(+258.8%) |
| Sept 2014 | - | 8.55%(-43.0%) |
| June 2014 | - | 15.01%(+14.2%) |
| Mar 2014 | - | 13.14%(+3.6%) |
| Dec 2013 | 23.32%(-1488.1%) | 12.68%(-16.1%) |
| Sept 2013 | - | 15.11%(-76.2%) |
| June 2013 | - | 63.58%(+395.6%) |
| Mar 2013 | - | 12.83%(+64.5%) |
| Dec 2012 | -1.68%(-105.2%) | 7.80%(-356.6%) |
| Sept 2012 | - | -3.04%(-93.1%) |
| June 2012 | - | -44.04%(-319.1%) |
| Mar 2012 | - | 20.10%(-44.5%) |
| Dec 2011 | 32.34%(-173.4%) | 36.22%(-149.8%) |
| Sept 2011 | - | -72.77%(+1188.0%) |
| June 2011 | - | -5.65%(-96.3%) |
| Dec 2010 | -44.07%(+781.4%) | - |
| Sept 2010 | - | -151.79%(+3029.7%) |
| June 2010 | - | -4.85%(-89.5%) |
| Mar 2010 | - | -46.16%(-312.5%) |
| Dec 2009 | -5.00%(-98.6%) | 21.72%(-4.8%) |
| Sept 2009 | - | 22.82%(-203.9%) |
| June 2009 | - | -21.96%(-59.3%) |
| Mar 2009 | - | -54.02%(-90.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2008 | -359.19%(-55.0%) | -562.01%(+62.7%) |
| Sept 2008 | - | -345.37%(+158.1%) |
| June 2008 | - | -133.83%(+65.9%) |
| Mar 2008 | - | -80.69%(-454.2%) |
| Sept 2007 | - | 22.78%(+77.4%) |
| June 2007 | - | 12.84%(-100.9%) |
| Dec 2006 | -798.16%(+124.0%) | - |
| June 2006 | - | -1501.22%(+219.6%) |
| Mar 2006 | - | -469.66%(<-9900.0%) |
| Dec 2005 | -356.26%(+784.9%) | 3.53%(-118.0%) |
| Sept 2005 | - | -19.63%(+0.7%) |
| June 2005 | - | -19.49%(-61.0%) |
| Mar 2005 | - | -49.94%(-13.8%) |
| Dec 2004 | -40.26%(-66.1%) | - |
| Sept 2004 | - | -57.93%(-15.3%) |
| June 2004 | - | -68.37%(+79.2%) |
| Mar 2004 | - | -38.16%(+7.7%) |
| Dec 2003 | -118.93%(+63.3%) | - |
| Sept 2003 | - | -35.44%(-14.0%) |
| June 2003 | - | -41.19%(-53.1%) |
| Mar 2003 | - | -87.88%(-91.8%) |
| Dec 2002 | -72.81%(+29.3%) | -1076.22%(+3758.8%) |
| Sept 2002 | - | -27.89%(-56.3%) |
| June 2002 | - | -63.89%(+141.8%) |
| Mar 2002 | - | -26.42%(-54.2%) |
| Dec 2001 | -56.32%(-62.6%) | -57.66%(+42.8%) |
| Sept 2001 | - | -40.39%(-33.5%) |
| June 2001 | - | -60.70%(-10.7%) |
| Mar 2001 | - | -67.98%(-26.0%) |
| Dec 2000 | -150.44%(-17.7%) | -91.85%(-6.9%) |
| Sept 2000 | - | -98.63%(-35.5%) |
| June 2000 | - | -152.81%(-42.8%) |
| Mar 2000 | - | -267.26%(+45.6%) |
| Dec 1999 | -182.71%(-72.6%) | -183.61%(-2.0%) |
| Sept 1999 | - | -187.40%(-17.1%) |
| June 1999 | - | -226.19%(+59.6%) |
| Mar 1999 | - | -141.75%(-85.0%) |
| Dec 1998 | -666.10%(+243.7%) | -946.51%(-20.3%) |
| Sept 1998 | - | -1187.18%(+200.2%) |
| June 1998 | - | -395.45%(+49.4%) |
| Mar 1998 | - | -264.71%(-15.3%) |
| Dec 1997 | -193.81%(+91.2%) | -312.39%(+174.7%) |
| Sept 1997 | - | -113.73%(+8.3%) |
| June 1997 | - | -105.05%(+1.9%) |
| Mar 1997 | - | -103.06%(-16.2%) |
| Dec 1996 | -101.36%(-61.3%) | -122.92%(+47.8%) |
| Sept 1996 | - | -83.17%(-29.3%) |
| June 1996 | - | -117.65%(+45.8%) |
| Mar 1996 | - | -80.68%(-24.1%) |
| Dec 1995 | -262.04%(+28.6%) | -106.33%(-17.4%) |
| Sept 1995 | - | -128.79%(-83.2%) |
| June 1995 | - | -768.52%(+509.5%) |
| Mar 1995 | - | -126.09%(-6.9%) |
| Dec 1994 | -203.76% | -135.42%(-20.5%) |
| Sept 1994 | - | -170.27%(-42.5%) |
| June 1994 | - | -296.00%(-1.3%) |
| Mar 1994 | - | -300.00% |
FAQ
- What is Ligand Pharmaceuticals Incorporated annual net profit margin?
- What is the all time high annual net margin for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated annual net margin year-on-year change?
- What is Ligand Pharmaceuticals Incorporated quarterly net profit margin?
- What is the all time high quarterly net margin for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated quarterly net margin year-on-year change?
What is Ligand Pharmaceuticals Incorporated annual net profit margin?
The current annual net margin of LGND is 39.72%
What is the all time high annual net margin for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high annual net profit margin is 57.00%
What is Ligand Pharmaceuticals Incorporated annual net margin year-on-year change?
Over the past year, LGND annual net profit margin has changed by +56.72% (+333.65%)
What is Ligand Pharmaceuticals Incorporated quarterly net profit margin?
The current quarterly net margin of LGND is -13.84%
What is the all time high quarterly net margin for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high quarterly net profit margin is 95.38%
What is Ligand Pharmaceuticals Incorporated quarterly net margin year-on-year change?
Over the past year, LGND quarterly net profit margin has changed by +17.42% (+55.73%)